Read about our COVID-19 Response.

Cerus Websites

Our Culture

Diversity and Inclusion

Cerus is committed to fostering and celebrating diversity across our entire company. Our mission to safeguard the world’s blood supply is inextricably and intentionally linked to this commitment. We believe that all patients – across cultures, languages, lifestyles, and backgrounds – must have access to safe blood when they need it. Through the contributions of our own many voices, experiences, and perspectives, we will advance together towards this goal.

Global Female Representation at Cerus:*

Greater than 60% of our global employees are female.*

%

Female staff - stat

Our Executive Leadership Team is comprised of over 50% female members.*

%

Women in leadership

Nearly 3/4 of our team of Scientists and Engineers are female.*

%

Women in leadership

More than half of promotions were female employees.*

%

Promotions at Cerus

More than 70% of our new hires were female.*

%

New Hires at Cerus

Global Representation:*

Cerus Employees Represent 28 Nationalities*

nationalities represented at Cerus

*full year 2020

We Value Diversity

Employee Spotlight

Employee Spotlight

Employee Spotlight

About Cerus

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE Mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of INTERCEPT Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. Follow us on LinkedIn.